Cargando…
Inhibition of the Insulin-Like Growth Factor-1 Receptor Enhances Effects of Simvastatin on Prostate Cancer Cells in Co-Culture with Bone
Prostate cancer (PC) bone metastases show weak responses to conventional therapies. Bone matrix is rich in growth factors, with insulin-like growth factor-1 (IGF-1) being one of the most abundant. IGF-1 acts as a survival factor for tumor cells and we speculate that bone-derived IGF-1 counteracts ef...
Autores principales: | Nordstrand, Annika, Lundholm, Marie, Larsson, Andreas, Lerner, Ulf H., Widmark, Anders, Wikström, Pernilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855371/ https://www.ncbi.nlm.nih.gov/pubmed/23335094 http://dx.doi.org/10.1007/s12307-013-0129-z |
Ejemplares similares
-
Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone
por: Nordstrand, Annika, et al.
Publicado: (2017) -
Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity
por: Nordstrand, Annika, et al.
Publicado: (2018) -
Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy
por: Wikström, Pernilla, et al.
Publicado: (2022) -
Prostate Tumor-Derived Exosomes Down-Regulate NKG2D Expression on Natural Killer Cells and CD8(+) T Cells: Mechanism of Immune Evasion
por: Lundholm, Marie, et al.
Publicado: (2014) -
Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti‐androgens
por: Ylitalo, Erik Bovinder, et al.
Publicado: (2019)